ANNA MANGUM COOK

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CHOCOWINITY, NC NPI 1548837636

General Payments — all program years on this page

$439.43

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 25
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $275.06 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $275.0615

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $67.534
Lilly USA, LLC $59.543
GlaxoSmithKline, LLC. $47.722
Amgen Inc. $46.943
Novo Nordisk AS $20.081
PFIZER INC. $19.571
ABBVIE INC. $13.681

By program year

Program yearAmountRecords
2022 $33.222
2023 $131.158
2024 $275.0615

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100285516 Novo Nordisk Inc $20.08 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104262623 AstraZeneca Pharmaceuticals LP $13.64 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104301568 AstraZeneca Pharmaceuticals LP $17.13 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104365975 AstraZeneca Pharmaceuticals LP $18.37 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104472004 AstraZeneca Pharmaceuticals LP $18.39 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106947050 ABBVIE INC. $13.68 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116103596 GlaxoSmithKline, LLC. $27.91 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116563086 GlaxoSmithKline, LLC. $19.81 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117531052 Amgen Inc. $16.16 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117531054 Amgen Inc. $15.71 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117531056 Amgen Inc. $15.07 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131114496 PFIZER INC. $19.57 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135504948 Lilly USA, LLC $22.41 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135518142 Lilly USA, LLC $19.25 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135535104 Lilly USA, LLC $17.88 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.